17.10.2022 • Topics

Investing in Growth Through Innovation

Interview with Marc Doyle, CEO of Arxada, which was created following the carve-out and sale of Lonza Specialty Ingredients to private equity firms Bain Capital and Cinven.

Company

Arxada AG

4052 Basel
Switzerland

Virtual Event

Outsourced Biomanufacturing

Strategic Outsourcing in Biopharmaceuticals

Outsourced Biomanufacturing

April 22, 2026 | Join biopharma professionals, CDMO leaders, and supply chain innovators for a virtual event exploring the future of outsourced biomanufacturing.

Expert Insights

ADCs for Precision Cancer Therapy

Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

Top-Feature

Global Impact Coalition (GIC)

Siemens Joins the Global Impact Coalition

Agilent Technologies Inc.

Comprehensive Insights into Antibody–Drug Conjugates (ADC) for Precision Cancer Therapy

CHEManager International c/o Wiley-VCH GmbH

Upcoming Virtual Events

Evonik Industries AG

Safer, Scalable Pharmaceutical Manufacturing with Flow Chemistry

most read

Topics • Chemistry

Q1 2025 Chemical Industry: Diverging Trends

The first quarter of 2025 highlights a continued divergence between the European and US chemical industries.

Topics • Pharma

Pharma 4.0—the Key Enabler for Successful Digital Transformation in Pharma

Part 3: Seven Theses for successful Digitalization in Pharma

Topics • Chemistry

US Tariffs Fatal for European Pharma

Trump's tariff policy is a considerable burden and a break with previous practice.

20 Years of CHEManager International

Incredible but true: CHEManager International is celebrating its 20th anniversary!

Topics • Pharma

Pharma 4.0 – the Key Enabler for Successful Digital Transformation in Pharma

Part 1: Building a Business Case for Pharma 4.0